Introduction {#Sec1}
============

Our understanding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) infection is rapidly evolving. The clinical presentation of patients infected with Coronavirus Disease 2019 (COVID-19) typically manifests as an acute respiratory illness with symptoms including fever, cough, and dyspnea \[[@CR1]\]. Most of the radiology studies on COVID-19 infection to date have focused on the lung findings in this population, which typically include multifocal, peripheral ground-glass opacities, consolidations, and crazy-paving \[[@CR2]--[@CR12]\].

However, there is growing evidence that the SARS-Cov-2 virus may also involve other organ systems such as the gastrointestinal and central nervous systems (CNS) \[[@CR13]--[@CR20]\]. A recent study described COVID-19 infection findings in the lung bases on CT abdomen studies performed on patients presenting with nausea, vomiting, and abdominal pain \[[@CR14]\]. CNS manifestations include non-respiratory symptoms such as altered mental status, seizures, and stroke-like symptoms possibly mediated by hypoxic-ischemic encephalopathy, demyelination, encephalitis, or cerebral thromboembolic disease \[[@CR15]--[@CR20]\]. In this population, imaging of the neck or cervical spine may be performed for a myriad of indications, including neck pain, trauma, or neck vascular imaging in the work-up of acute ischemic stroke. A systematic approach to interpreting these studies should include an evaluation of the upper lungs and mediastinum included within the field of view \[[@CR21]\].

The purpose of this study was to evaluate the prevalence and characteristics of COVID-19 lung findings detected in patients undergoing CT of the neck or cervical spine.

Methods and materials {#Sec2}
=====================

Study cohort {#Sec3}
------------

This was a retrospective, IRB-approved study performed at a single, large academic hospital in Boston, Massachusetts. Between March 3, 2020, and May 6, 2020, a total of 641 patients received medical care at our hospital for SARS-CoV-2. Included in this study were patients in our emergency department who underwent CT imaging of the neck and cervical spine, which includes the lung apices, and who also tested positive for SARS-CoV-2 via reverse transcriptase polymerase chain reaction (RT-PCR). Exclusion criteria included patients with CT examinations with severe motion artifact precluding a diagnostic assessment, neck CT examinations which included less than 8 consecutive axial images through the lung apices, and patients with suspected SARS-CoV-2 infection but tested negative on RT-PCR.

Clinical data {#Sec4}
-------------

Basic demographic information for each patient was recorded including age and gender. Date of RT-PCR test positivity and presenting clinical symptoms were also recorded for each patient and included fever, cough, and gastrointestinal symptoms such as nausea/vomiting/diarrhea and loss of appetite.

Imaging technique {#Sec5}
-----------------

CT examinations were obtained on 64-slice MDCT scanners and protocols included in this study were CT angiograms of the neck, contrast-enhanced CT of the neck, and non-contrast CT of the cervical spine. CT examinations were performed on either a Revolution CT (GE Healthcare, Milwaukee, Wisconsin) or a Force CT (Siemens, Erlangen, Germany).

Non-contrast cervical spine CTs were helically acquired (120-kV/auto-mAs) with 1.25-mm thick slices from the level of the skull base to the thoracic inlet. Soft tissue and bone algorithms were available for review with 1.5--2 mm thick/interval coronal and sagittal reconstructions.

CT angiogram images of the neck were obtained from the level of the aortic arch through the superior orbital rim with 0.625--1.25 mm thick slices (120-kVp/auto-mAs), following a dose of 80--100 mL of iohexol (Omnipaque, GE Healthcare, Milwaukee, Wisconsin) or iopamidol (Isovue, Bracco, Princeton, New Jersey), 370 mg/mL administered by a power injector at a rate of 4--5 mL/s. Coronal and sagittal reformatted images at 2-mm thick slices were reconstructed.

Contrast-enhanced CT neck images were helically acquired (120-kV/auto-mAs) with 1.25-mm thick slices following a 60-s delay following intravenous contrast administration (80--160 mL of iohexol or iopamidol, 370mgI/mL) from the level of the skull base through the aortic arch. Soft tissue and bone algorithms were available for review with 2-mm thick/interval coronal and sagittal reconstructions.

Image evaluation {#Sec6}
----------------

The type of CT examination each patient underwent (CT angiogram of the neck, contrast-enhanced CT of the neck, and cervical spine CT) was recorded. The date and time the neck imaging was performed were also recorded. Many of the patients in this cohort also underwent chest CT imaging. If a chest CT was performed at our institution during the course of the patient's admission, the date and time of the chest CT were recorded.

The visualized portions of the lung apices were evaluated by a neuroradiology attending and a diagnostic radiology resident. Lung apices were evaluated for the presence of ground glass opacities, focal alveolar consolidation, and evidence of crazy paving (interlobular septal thickening on a background of ground-glass opacity).

Data analysis {#Sec7}
-------------

The frequency of detection of lung apical findings related to suspected COVID-19 pneumonia and type of lung findings were calculated in our cohort. The temporal relationship between reported lung apical findings on neck CT examinations and RT-PCR positive testing results was also evaluated. The cohort was further stratified into patients where neck CT imaging was performed prior to chest CT imaging and when neck CT imaging was performed concurrently with chest CT imaging.

Results {#Sec8}
=======

A total of 37 patients met the inclusion criteria for this study, which included 15 females and 22 males (Fig. [1](#Fig1){ref-type="fig"}). Three patients were not analyzed since their CT neck or spine imaging occurred after a CT chest study. The mean age was 55 years (standard deviation 17 years, range: 30--96). The indications for cervical spine or neck imaging included the following: stroke, trauma, and neck pain (Table [1](#Tab1){ref-type="table"}).Fig. 1Flow chart of patient imaging findingsTable 1Patient demographic, clinical, and imaging dataDemographics  Age60 mean (SD [+]{.ul} 17); range 30--96  Males/females22 M (59%): 15 F (41%)Symptoms  Fever13 (35%)  Respiratory symptoms26 (70%)  Gastrointestinal symptoms5 (14%)Neuro CT indications  Stroke16 (43%)  Trauma14 (19%)  Neck pain7 (19%)Type of CT imaging  CTA neck22 (59%)  NECT cervical spine8 (22%)  CECT neck7 (19%)Lung findings on CT  Absent lung findings10 (29%)  Present lung findings24 (71%)    Ground-glass opacities22 (67%)    Consolidation14 (42%)    Crazy-paving3 (9%)Temporal relationship of neck CTs  CT before RT-PCR results17 (46%)  CT after RT-PCR results20 (54%)  Neck CT concurrent with chest CT21 (57%)  Neck CT before chest CT13 (37%)  Neck CT after chest CT3 (8%)*SD* standard deviation, *M* males, *F* females, *CTA* CT angiogram, *NECT* non-contrast CT, *CECT* contrast-enhanced CT, *RT-PCR* reverse transcriptase polymerase chain reaction

Thirty-four patients underwent neck or cervical spine CT imaging either preceding or contemporaneously with a CT chest study. Twenty-four (71%) patients had CT studies demonstrating COVID-19 findings in the lung apices including ground glass opacities in 22 patients (67%), consolidation in 14 patients (42%), and "crazy-paving" pattern in 3 patients (9%). Of all 34 patients, 17 (50%) had unknown COVID-19 status at the time of neck or spine imaging, and 10 (59%) of their CT studies had findings in the lung apices consistent with COVID-19 pneumonia (Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). Twelve out of 17 (71%) patients with unknown COVID-19 status at the time of imaging had respiratory symptoms or fever.Fig. 2Axial image from a non-contrast cervical spine CT in an 84-year-old female presenting after an unwitnessed fall at home and unknown COVID-19 status. Images of the lung apices demonstrate peripheral, multifocal ground glass opacities (white arrows) with areas of consolidation (white arrowheads), a "typical appearance" of COVID-19 \[[@CR2]\]. The patient subsequently tested COVID-19 positiveFig. 3Axial image from non-contrast cervical spine CT in a 56-year-old male found down, unresponsive, and febrile with unknown COVID-19 status. Lung apices demonstrate peripheral, bilateral, ground glass opacities with visible interlobular lines (crazy-paving pattern (white arrow)), a "typical appearance" of COVID-19 \[[@CR2]\]. The patient subsequently tested COVID-19 positive

There were 4 (12%) patients who had an unknown COVID-19 status at the time of CT cervical spine or neck imaging and had no preceding or contemporaneous CT chest imaging. Of these patients, 2 had findings in the lung apices consistent with COVID-19 pneumonia.

Discussion {#Sec9}
==========

In this study, 59% of patients with undiagnosed SARS-CoV-2 infection demonstrated apical lung findings suggestive of COVID-19 pneumonia on neck or cervical spine CT imaging. The most common manifestation of these findings was the presence of apical ground glass opacities followed by consolidation. Twelve percent of the patients in this cohort with undiagnosed SARS-CoV-2 infection had neck and/or cervical spine CT imaging preceding chest imaging. Furthermore, half of this subset of patients exhibited findings in the lung apex consistent with COVID-19 pneumonia and suspicion for infection was first raised in the emergency radiology report.

These results highlight the importance for emergency radiologists to be familiar with the patterns of COVID-19 lung disease, as they may be the first to encounter evidence of underlying SARS-CoV-2 infection and should be prepared to expeditiously alert the referring providers to these findings. These findings are consistent with prior literature as Kihira et al. reported that approximately 28% of patients undergoing a CT angiogram of the head and neck for stroke had apical lung findings concerning for COVID pneumonia \[[@CR22]\]. Similarly, Hossain et al. found findings related to incidental COVID-19 pneumonia in a cohort of 18 patients who underwent neck imaging and 101 patients who underwent abdominal imaging \[[@CR23]\]. A case report performed by Barajas et al. illustrated apical lung CT findings consistent with COVID-19 pneumonia on a patient undergoing a cervical spine CT for trauma evaluation \[[@CR24]\]. Our study further emphasizes the importance of radiologist diligence when examining the visualized lung fields on multiple types of modality, including neck CT angiogram, CECT neck, and NECT cervical spine studies.

There are limitations to this study. The sample size is relatively small. While many patients underwent imaging evaluation at our institution related to symptoms of COVID-19 infection, imaging of the neck was relatively infrequent. Secondly, based on patient size and patient positioning, different amounts of the lung apices were visible on the neck and cervical spine CT examinations. We set a threshold of having at least 8 consecutive axial images present in the lung apices for inclusion into this study; however, several patients had substantially larger amounts of lung parenchyma visible on these CT examinations than others. In patients with relatively smaller amounts of visible lung tissue on CT, there may be potential findings of COVID-19 related pneumonia that were not included in the field of view.

The results of this study demonstrate that 59% of our patients with unknown COVID-19 status who underwent CT neck or cervical spine demonstrated imaging findings in the visualized portion of the lung apices consistent with COVID-19 pneumonia. This highlights the importance for emergency radiologists to be familiar with lung manifestations of COVID-19 pneumonia to ensure prompt diagnosis and treatment, even in instances where patients have no respiratory symptoms.
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